Related Experiment Video
Updated: Aug 17, 2026
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Melanotic neuroectodermal tumor of infancy
J C George1, M K Edwards, R I Jakacki
1Department of Radiology, Indiana University School of Medicine, James Whitcomb Riley Hospital for Children, Indianapolis 46202-5200, USA.
Abstract:
We present a case of malignant melanotic neuroectodermal tumor of infancy arising in the skull and secondarily invading brain. The central tumor was hyperintense to brain on T1-weighted images and hypointense to brain on T2-weighted images. This appearance corresponded to the surgical and histologic findings of melanin-containing tumor.
Insights
A rare malignant melanotic neuroectodermal tumor of infancy was found in the skull, invading the brain. Imaging showed the melanin-rich tumor was bright on T1 and dark on T2 MRI sequences.
Area of Science:
- Pediatric Oncology
- Neuroimaging
- Surgical Pathology
Background:
- Malignant melanotic neuroectodermal tumor of infancy (MMTNI) is a rare, aggressive neoplasm.
- Primary MMTNI typically occurs in the head and neck region, with cranial vault involvement being uncommon.
Observation:
- A case of MMTNI arising in the skull with secondary brain invasion is presented.
- The tumor exhibited specific signal characteristics on magnetic resonance imaging (MRI).
Findings:
- On T1-weighted MRI sequences, the central tumor appeared hyperintense relative to brain tissue.
- On T2-weighted MRI sequences, the central tumor appeared hypointense relative to brain tissue.
- These imaging findings correlated with the presence of melanin within the tumor upon surgical resection and histological examination.
Implications:
- This case highlights the importance of recognizing MMTNI in the skull, even with secondary brain invasion.
- Specific MRI signal characteristics can aid in the preoperative diagnosis of melanin-containing tumors.
- Early and accurate diagnosis is crucial for appropriate management and improved outcomes in pediatric neuro-oncology.
